We investigated the correlation of CtBP1/2 genetic alterations with patient overall survival time in serous ovarian cancer patients using TCGA cases to validate the results that disruption of CtBP proteins function would lead to cancer cell apoptosis and increase DNA instability. This evidence concerns the gene CTBP1 and cancer.